EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,777 | -19.4% | 112,666 | -0.7% | 0.65% | -6.4% |
| Q2 2023 | $2,205 | -31.7% | 113,437 | -0.3% | 0.70% | -28.7% |
| Q1 2023 | $3,227 | -3.8% | 113,737 | -0.9% | 0.98% | -5.5% |
| Q4 2022 | $3,356 | -99.9% | 114,825 | -5.2% | 1.04% | +1.8% |
| Q3 2022 | $3,199,000 | -40.5% | 121,083 | +0.1% | 1.02% | -42.7% |
| Q2 2022 | $5,377,000 | -5.4% | 121,014 | +5.4% | 1.78% | -9.2% |
| Q1 2022 | $5,681,000 | +4.8% | 114,787 | +7.8% | 1.96% | +4.1% |
| Q4 2021 | $5,422,000 | -9.8% | 106,487 | -1.2% | 1.88% | -0.3% |
| Q3 2021 | $6,012,000 | +98.4% | 107,773 | +52.2% | 1.89% | +83.3% |
| Q2 2021 | $3,030,000 | – | 70,804 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |